# Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme

> **NCT01233492** · PHASE1 · TERMINATED · sponsor: **Cancer Research UK** · enrollment: 36 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** boron phenylalanine
- **DRUG:** mannitol
- **OTHER:** biologic sample preservation procedure
- **RADIATION:** radiation therapy treatment planning/simulation

## Key facts

- **NCT ID:** NCT01233492
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 36 (ESTIMATED)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2013-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01233492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01233492, "Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01233492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*